This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Eyepoint Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Said Saim in Ocular Drug Delivery
Introduction
Said Saim is an accomplished inventor based in Watertown, MA (US). He has made significant contributions to the field of ocular drug delivery through his innovative inventions. His work focuses on improving therapeutic methods for eye treatments.
Latest Patents
Said Saim holds a patent for a bioerodible ocular drug delivery insert and therapeutic method. This invention relates to implantable bioerodible inserts designed for delivering active pharmaceutical ingredients directly to the eye. The patent also encompasses methods of treatment utilizing these inserts, as well as the manufacturing processes involved in creating them. He has 1 patent to his name.
Career Highlights
Said Saim is currently employed at Eyepoint Pharmaceuticals, Inc., where he continues to develop innovative solutions for ocular health. His expertise in drug delivery systems has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Said has collaborated with notable colleagues, including Michelle Howard-Sparks and Dario Paggiarino. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic methods.
Conclusion
Said Saim's contributions to ocular drug delivery represent a significant advancement in the field. His innovative patent and ongoing work at Eyepoint Pharmaceuticals, Inc. highlight his commitment to improving patient care through effective drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile